azauridine has been researched along with Congenital Zika Syndrome in 2 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morales Vasquez, D | 1 |
| Park, JG | 1 |
| Ávila-Pérez, G | 1 |
| Nogales, A | 1 |
| de la Torre, JC | 1 |
| Almazan, F | 1 |
| Martinez-Sobrido, L | 1 |
| Adcock, RS | 1 |
| Chu, YK | 1 |
| Golden, JE | 1 |
| Chung, DH | 1 |
2 other studies available for azauridine and Congenital Zika Syndrome
| Article | Year |
|---|---|
Identification of Inhibitors of ZIKV Replication.
Topics: A549 Cells; Animals; Antiviral Agents; Apoptosis; Azauridine; Biphenyl Compounds; Carbamates; Cell S | 2020 |
Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Topics: Animals; Antiviral Agents; Azauridine; Biphenyl Compounds; Chlorocebus aethiops; Cytopathogenic Effe | 2017 |